Publications & Reports

Dimeric FcgammaR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG.

Wines BD, Vanderven HA, Esparon SE, Kristensen AB, Kent SJ, Hogarth PM
Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria 3004, Australia; Department of Immunology, Monash University Central Clinical School, Melbourne, Victoria 3004, Australia; Department of Pathology, The University of Melbourne, Melbourn

Abstract

Ab-dependent cellular cytotoxicity, phagocytosis, and Ag presentation are key mechanisms of action of Abs arising in vaccine or naturally acquired immunity, as well of therapeutic mAbs. Cells expressing the low-affinity FcgammaRs (FcgammaRII or CD32 and FcgammaRIII or CD16) are activated for these functions when receptors are aggregated following the binding of IgG-opsonized targets. Despite the diversity of the Fc receptor proteins, IgG ligands, and potential responding cell types, the induction of all FcgammaR-mediated responses by opsonized targets requires the presentation of multiple Fc regions in close proximity to each other. We demonstrated that such “near-neighbor” Fc regions can be detected using defined recombinant soluble (rs) dimeric low-affinity ectodomains (rsFcgammaR) that have an absolute binding requirement for the simultaneous engagement of two IgG Fc regions. Like cell surface-expressed FcgammaRs, the binding of dimeric rsFcgammaR ectodomains to Ab immune complexes was affected by Ab subclass, presentation, opsonization density, Fc fucosylation, or mutation. The activation of an NK cell line and primary NK cells by human IgG-opsonized influenza A hemagglutinin correlated with dimeric rsFcgammaRIIIa binding activity but not with Ab titer. Furthermore, the dimeric rsFcgammaR binding assay sensitively detected greater Fc receptor activity to pandemic H1N1 hemagglutinin after the swine influenza pandemic of 2009 in pooled human polyclonal IgG. Thus these dimeric rsFcgammaR ectodomains are validated, defined probes that should prove valuable in measuring the immune-activating capacity of IgG Abs elicited by infection or vaccination or experimentally derived IgG and its variants.

Publisher’s web site

Publication

  • Journal: Journal of Immunology
  • Published: 06/07/2016
  • Volume: 197
  • Issue: 4
  • Pagination: 1507-1516

Authors